Prothena Corp. (PRTA) Misses Q4 EPS by 29c

Prothena Corp. (NASDAQ: PRTA) reported Q4 EPS of ($1.41), $0.29 worse than the analyst estimate of ($1.12). Revenue for the quarter came in at $170 thousand versus the consensus estimate of $5.35 million.

For earnings history and earnings-related data on Prothena Corp. (PRTA) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
• CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance